Arkolith/Insider Trading/LBRX/Form 4

Soffer Gad

Chief Business OfficerLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Grant(A)230K—$0230K
Sep 10, 2025Disposed to issuer(D)27K——0
Sep 10, 2025Grant(A)27K——27K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-024443) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML